1-20 of 22
Patrice Nasnas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictors of Veno-Occlusive Disease (VOD) of the Liver in Patients Treated with Inotuzumab Ozogamicin (InO) Containing Regimen in B-Cell Acute Lymphoblastic Leukemia

Jayastu Senapati, Elias Jabbour, Nicholas Short, Nitin Jain, Partow Kebriaei, Richard E Champlin, Issa F. Khouri, Elizabeth J Shpall, Patrice Nasnas, Aram Bidikian, Rebecca Garris, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 3155–3157.
https://doi.org/10.1182/blood-2022-171189
Published: 2022
Journal Articles

Baseline Liver Elastography Does Not Predict Risks of Hepato-Toxicity to Reduced Dose Inotuzumab Therapy Combined with Minihcvd in B-Cell Acute Lymphoblastic Leukemia

Jayastu Senapati, Nicholas Short, Nitin Jain, Farhad Ravandi, Tharakeswara K. Bathala, Aram Bidikian, Fadi Haddad, Patrice Nasnas, Naval Daver, Tapan M. Kadia, Rebecca Garris, Monica Kwari, Hagop Kantarjian, Elias Jabbour
Journal: Blood
Blood (2022) 140 (Supplement 1): 3182–3184.
https://doi.org/10.1182/blood-2022-170931
Published: 2022
Journal Articles

Frontline Combination of Hyper-CVAD with Ponatinib for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia-6-Year Follow-up Results

Patrice Nasnas, Elias Jabbour, Nicholas Short, Koji Sasaki, Farhad Ravandi, Nitin Jain, Naval Daver, Naveen Pemmaraju, Musa Yilmaz, Tapan M. Kadia, Rebecca Garris, Guillermo Garcia-Manero, Courtney D. DiNardo, Marina Konopleva, William G. Wierda, Monica Kwari, Christopher Loiselle, Anna Milton, Juan Rivera, Glenda Banks, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 3250–3252.
https://doi.org/10.1182/blood-2022-167761
Published: 2022
Journal Articles

Improved Outcomes with Low-Dose Inotuzumab and Mini-Hyper-CVD Followed By Blinatumomab Consolidation in Relapsed-Refractory Acute Lymphoblastic Leukemia: Results of a Phase II Study

Fadi Haddad, Elias Jabbour, Nicholas Short, Nitin Jain, Emmanuel Almanza Huante, Koji Sasaki, Patrice Nasnas, Farhad Ravandi, Partow Kebriaei, Xuelin Huang, Marina Konopleva, Guillermo Garcia-Manero, Richard E Champlin, Tapan M. Kadia, Koichi Takahashi, Naval Daver, Joseph D. Khoury, Jeffrey L. Jorgensen, Sa A Wang, Jovitta Jacob, Rebecca Garris, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 11698–11701.
https://doi.org/10.1182/blood-2022-170049
Published: 2022
Journal Articles

A Phase II Study of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia: Updated Results and Predictors for Outcomes

Patrice Nasnas, Elias Jabbour, Nicholas Short, Farhad Ravandi, Xuelin Huang, Nitin Jain, Tapan M. Kadia, Yesid Alvarado, Jan A. Burger, Naval Daver, Gautam Borthakur, Courtney D. DiNardo, Marina Konopleva, Guillermo Garcia-Manero, William G. Wierda, Jovitta Jacob, Wuliamatu Deen, Monica Kwari, Christopher Loiselle, Edith Roy, Anna Milton, Juan Rivera, Rebecca Garris, Hagop Kantarjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 11679–11682.
https://doi.org/10.1182/blood-2022-168052
Published: 2022
Journal Articles

Impact of Molecular Response at Specific Timepoints in Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Second Generation Tyrosine Kinase Inhibitors

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Ghayas C. Issa, MD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, William G. Wierda, MD PhD, Musa Yilmaz, MD, Courtney D. DiNardo, MD MSCE, Jeffrey Skinner, MHA, Rita Khouri, Naveen Pemmaraju, MD, Patrice Nasnas, MD, Sara E Dellasala, BS, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-143023
Published: 2020
Journal Articles

Outcome of Patients with Chronic Myeloid Leukemia in Lymphoid Blast Crisis (CML-LBC) and Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) Treated with Hyper-CVAD and Dasatinib

Kiyomi Morita, MDPhD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Koji Sasaki, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Nicholas J. Short, MD, Koichi Takahashi, MD PhD, Rita Khouri, Patrice Nasnas, MD, Courtney D. DiNardo, MD MSCE, Tapan M. Kadia, MD, Guillermo Garcia-Manero, MD, Naval Daver, MD, Guillermo Montalban Bravo, MD, Ghayas C. Issa, MD, Jorge E. Cortes, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–48.
https://doi.org/10.1182/blood-2020-141230
Published: 2020
Journal Articles

Roleof Allogeneic Stem Cell Transplant (ASCT) in Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab (Blina): Results from a Phase 2 Study

Hind Rafei, MD, Hagop M. Kantarjian, MD, Koji Sasaki, MD, Nicholas J. Short, MD, Farhad Ravandi, MBBS, Xuelin Huang, PhD, Joseph D. Khoury, MD, Sa A Wang, MD, Jeffrey L. Jorgensen, MD PhD, Issa F. Khouri, MD, Partow Kebriaei, MD, Richard E. Champlin, MD, Nitin Jain, MD, Bouthaina S. Dabaja, MD, Ghayas C. Issa, MD, Naveen Pemmaraju, MD, Tapan M. Kadia, MD, Shilpa Paul, PharmD, Nadya Jammal, PharmD, Guillermo Garcia-Manero, MD, William G. Wierda, MD PhD, Courtney D. DiNardo, MD MSCE, Naval Daver, MD, Guillermo Montalban-Bravo, MD, Rita Khouri, Patrice Nasnas, MD, Philip A. Thompson, MB, MS, Jovitta Jacob, Meagan Rostykus, RN, Rebecca Garris, MSc, Marina Konopleva, MD PhD, Susan M. O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–41.
https://doi.org/10.1182/blood-2020-143286
Published: 2020
Journal Articles

Impact of Cytogenetic Abnormalities (CA) on Outcome of Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab: Results from a Phase 2 Study

Hind Rafei, MD, Hagop M. Kantarjian, MD, Koji Sasaki, MD, Nicholas J. Short, MD, Farhad Ravandi, MBBS, Xuelin Huang, PhD, Joseph D. Khoury, MD, Sa A Wang, MD, Jeffrey L. Jorgensen, MD PhD, C. Cameron Yin, MD PhD, Issa F. Khouri, MD, Partow Kebriaei, MD, Nitin Jain, MD, Koichi Takahashi, MD PhD, Bouthaina S. Dabaja, MD, Srdan Verstovsek, MD PhD, Tapan M. Kadia, MD, Shilpa Paul, PharmD, Caitlin R. Rausch, PharmD, Guillermo Garcia-Manero, MD, William G. Wierda, MD PhD, Courtney D. DiNardo, MD MSCE, Naval Daver, MD, Guillermo Montalban-Bravo, MD, Musa Yilmaz, MD, Patrice Nasnas, MD, Rita Khouri, Monica Kwari, BSN, Jovitta Jacob, Meagan Rostykus, RN, Rebecca Garris, MSc, Marina Konopleva, MD PhD, Susan M. O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–47.
https://doi.org/10.1182/blood-2020-143401
Published: 2020
Journal Articles

Outcomes of Patients with Chronic Myeloid Leukemia Treated with Third-Line Tyrosine Kinase Inhibitors

Koji Sasaki, MD, Elias Jabbour, MD, Ghayas C. Issa, MD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, William G. Wierda, MD PhD, Musa Yilmaz, MD, Courtney D. DiNardo, MD MSCE, Jeffrey Skinner, MHA, Maria Khouri, Naveen Pemmaraju, MD, Patrice Nasnas, MD, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-142954
Published: 2020
Journal Articles

Sequential Combination of Inotuzumab Ozogamicin (InO) with Low-Intensity Chemotherapy (Mini-hyper-CVD) with or without Blinatumomab Is Highly Effective in Patients (pts) with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Nicholas J. Short, MD, Partow Kebriaei, MD, Xuelin Huang, PhD, Michael E. Rytting, MD, Nitin Jain, MD, Marina Y Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Richard E. Champlin, MD, Tapan M. Kadia, MD, Jorge E. Cortes, MD, Zeev E. Estrov, MD, Koichi Takahashi, MD, Christopher Loiselle, BS, Corabelle Encarnacion, RDC, Meagan Rostykus, RN, Rita Khouri, Patrice Nasnas, MD, Jovitta Jacob, RN, Monica Kwari, BSN, Rebecca Garris, MSc, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3806.
https://doi.org/10.1182/blood-2019-129018
Published: 2019
Journal Articles

The Impact of Smoking on Survival in Patients (Pts) with Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Treated with the Combination of Intensive Therapy with Tyrosine Kinase Inhibitor (TKI)

Koji Sasaki, MD, Josep-Maria Ribera, MD PhD, Mary Figueroa, BS, Farhad Ravandi, MD, Nicholas J. Short, MD, Guillermo Garcia-Manero, MD, Naval G. Daver, MD, Tapan M. Kadia, MD, Marina Y Konopleva, MD PhD, Nitin Jain, MD, Ghayas C. Issa, MD, Zeev E. Estrov, MD, Rebecca Garris, MSc, Rita Khouri, Patrice Nasnas, MD, Courtney D. DiNardo, MDMSc, Kiran Naqvi, MDMPH, Steven M. Kornblau, MD, Guillermo Montalban-Bravo, MD, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Joya Chandra, PhD, Hagop M. Kantarjian, MD, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3815.
https://doi.org/10.1182/blood-2019-129396
Published: 2019
Journal Articles

Phase II Study of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia (B-ALL) with Positive Measurable Residual Disease (MRD)

Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Jeffrey L. Jorgensen, MD PhD, Sa A Wang, MD, Joseph D. Khoury, MD, Farhad Ravandi, MD, Nicholas J. Short, MD, Rita Khouri, Koichi Takahashi, MD, Maro Ohanian, DO, Gautam M. Borthakur, MD, Marina Y Konopleva, MD PhD, Naval G. Daver, MD, Zeev E. Estrov, MD, Yesid Alvarado, MD, Nitin Jain, MD, Tapan M. Kadia, MD, Guillermo Garcia-Manero, MD, Michelle Velasquez, RN, Patrice Nasnas, MD, Susan O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1299.
https://doi.org/10.1182/blood-2019-130283
Published: 2019
Journal Articles

Long Term Follow-up on Phase 2 Study on the Efficacy and Safety of Blinatumomab in Adult Patients with Relapsed Refractory B-Precursor Acute Lymphoblastic Leukemia

Iman Aboudalle, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Farhad Ravandi, MD, Koji Sasaki, MD, Guillermo Garcia-Manero, MD, Guillermo Montalban-Bravo, MD, Jorge E. Cortes, MD, Christopher B. Benton, MD, Ghayas C. Issa, MD, Maria Khouri, Patrice Nasnas, MD, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4017.
https://doi.org/10.1182/blood-2018-99-117507
Published: 2018
Journal Articles

Safety and Efficacy of Blinatumomab in Patients with Central Nervous System (CNS) Disease: A Single Institution Experience

Mansour Alfayez, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Rita Assi, MD, Maria Khouri, Farhad Ravandi, MD, Shilpa Paul, PharmD, Caitlin R. Rausch, PharmD, Patrice Nasnas, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MDMSc, Tapan M. Kadia, MD, Naval G. Daver, MD, Guillermo Garcia-Manero, MD, Kiran Naqvi, MD MPH, Prithviraj Bose, MD, Susan M. O'Brien, MD, Jorge E. Cortes, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2702.
https://doi.org/10.1182/blood-2018-99-117400
Published: 2018
Journal Articles

Smoking Confers Poor Survival in Patients (Pts) with Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Treated with the Combination of Intensive Therapy with Tyrosine Kinase Inhibitor (TKI)

Elias J. Jabbour, MD, Koji Sasaki, MD, Farhad Ravandi, MD, Nicholas J Short, MD, Guillermo Garcia-Manero, MD, Naval G. Daver, MD, Tapan M. Kadia, MD, Marina Y. Konopleva, MD PhD, Nitin Jain, MD, Ghayas C. Issa, MD, Zeev E. Estrov, MD, Rebecca E. Garris, MSc, Maria Khouri, Patrice Nasnas, MD, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2664.
https://doi.org/10.1182/blood-2018-99-115325
Published: 2018
Journal Articles

Dynamic Personalized Assessment of Outcome in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Koji Sasaki, MD, Elias J. Jabbour, MD, Farhad Ravandi, MD, Nicholas J Short, MD, Guillermo Garcia-Manero, MD, Naval G. Daver, MD, Tapan M. Kadia, MD, Marina Y. Konopleva, MD PhD, Nitin Jain, MD, Ghayas C. Issa, MD, Victoria Jeanis, RN, Joie Alvarez, RN, Maria Khouri, Patrice Nasnas, MD, Rebecca E. Garris, MSc, William G. Wierda, MD PhD, Philip A. Thompson, MBBS, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2695.
https://doi.org/10.1182/blood-2018-99-115212
Published: 2018
Journal Articles

Chemoimmunotherapy with Inotuzumab Ozogamicin Combined with Mini-Hyper-CVD, with or without Blinatumomab, for Newly Diagnosed Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study

Nicholas J Short, MD, Elias J. Jabbour, MD, Farhad Ravandi, MD, Xuelin Huang, PhD, Nitin Jain, MD, Koji Sasaki, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Joseph David Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Yesid Alvarado, MD, Marina Y. Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, Musa Yilmaz, MD, Gautam Borthakur, MD, Jan A. Burger, MD PhD, Steven M. Kornblau, MD, William G. Wierda, MD PhD, Courtney D. DiNardo, MDMSc, Alessandra Ferrajoli, MD, Patrice Nasnas, MD, Jovitta Jacob, RN, Rebecca E. Garris, MSc, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 36.
https://doi.org/10.1182/blood-2018-99-114955
Published: 2018
Journal Articles

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) Vs. Standard Intensive Chemotherapy (hyper-CVAD) As Frontline Therapy for Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL): A Propensity Score Analysis

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Farhad Ravandi, MD, Maria Khouri, Guillermo Garcia-Manero, MD, Naval G. Daver, MD, Tapan M. Kadia, MD, Marina Y. Konopleva, MD PhD, Nitin Jain, MD, Ghayas C. Issa, MD, Jovitta Jacob, RN, Rebecca E. Garris, MSc, Musa Yilmaz, MD, Philip A. Thompson, MBBS, Patrice Nasnas, MD, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 34.
https://doi.org/10.1182/blood-2018-99-115271
Published: 2018
Journal Articles

Phase II Study of Blinatumomab in Patients with B-Cell Lineage Acute Lymphocytic Leukemia with Positive Minimal/Measurable Residual Disease

Iman Aboudalle, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Maria Khouri, Koichi Takahashi, MD, Maro N. Ohanian, DO, Gautam Borthakur, MD, Marina Y. Konopleva, MD PhD, Naval G. Daver, MD, Zeev E. Estrov, MD, Yesid Alvarado, MD, Nitin Jain, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Michelle Velasquez, RN, Patrice Nasnas, MD, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5212.
https://doi.org/10.1182/blood-2018-99-119685
Published: 2018